process
calibr
model
hiv
preval
data
hiv
diagnosi
data
mortal
data
previous
describ
briefli
model
calibr
agespecif
hiv
preval
data
antenat
survey
conduct
period
ageand
sexspecif
hiv
preval
data
nation
household
survey
conduct
ageand
sexspecif
record
death
statist
period
model
also
calibr
selfreport
data
past
hiv
test
nation
household
survey
allow
potenti
misreport
total
estim
number
hiv
test
perform
south
africa
estim
number
hivposit
test
result
triangul
hiv
preval
data
survey
mortal
data
routin
hiv
test
data
ensur
model
captur
accur
profil
hivposit
south
african
popul
period
model
simul
four
type
hiv
test
test
gener
popul
test
antenat
clinic
test
hivposit
individu
experi
opportunist
infect
test
individu
receiv
preexposur
prophylaxi
model
mode
test
describ
previous
period
consid
fifth
type
test
test
mobil
clinic
although
could
consid
variat
test
gener
popul
like
ageand
sex
profil
patient
reach
multidiseas
screen
intervent
would
differ
achiev
hiv
screen
programm
averag
annual
fraction
popul
reach
mobil
test
multipli
ageand
sexspecif
adjust
factor
shown
tabl
assumpt
deriv
use
data
multidiseas
screen
programm
uganda
found
rel
high
rate
screen
uptak
women
older
adult
averag
annual
proport
adult
popul
age
older
screen
set
estim
uptak
mobil
test
servic
populationbas
studi
inconsist
labhardt
et
al
found
lesotho
individu
particip
mobil
multidiseas
screen
programm
commun
month
median
commun
size
data
therefor
suggest
uptak
rate
howev
chami
et
al
found
substanti
higher
rate
uptak
similar
mobil
multidiseas
screen
programm
introduc
uganda
uptak
period
possibl
high
rate
uptak
achiev
result
signific
prior
commun
mobil
studi
investig
uptak
hiv
test
offer
mobil
servic
continu
basi
rather
part
onceoff
campaign
kranzer
et
al
found
cape
town
commun
approxim
adult
receiv
mobil
hiv
test
period
suggest
annual
screen
rate
higher
rate
hiv
test
found
accept
trial
involv
mobil
test
servic
conjunct
commun
mobil
tanzania
zimbabw
tanzania
individu
test
popul
individu
month
zimbabw
individu
test
popul
individu
month
data
suggest
annual
test
rate
respect
estim
number
individu
screen
intervent
obtain
multipli
popul
size
popul
age
sex
categori
correspond
mobil
test
rate
sum
across
period
juli
june
uptak
screen
assum
independ
hiv
statu
hivposit
individu
would
benefit
diabet
hypertens
screen
even
alreadi
knew
hiv
statu
diagnos
mobil
test
programm
individu
assum
probabl
start
art
averag
probabl
linkag
care
estim
recent
systemat
review
metaanalysi
mobil
hiv
test
intervent
hivdiagnos
individu
also
assum
less
like
engag
unprotect
sex
compar
undiagnos
hivposit
individu
unprotect
sex
assum
reduc
art
reduct
infecti
art
initi
assum
depend
level
viral
suppress
describ
elsewher
hiv
diagnosi
art
initi
thu
assum
associ
substanti
reduct
hiv
transmiss
potenti
although
thembisa
model
directli
simul
incid
preval
diabet
hypertens
output
model
number
individu
screen
combin
survey
data
estim
number
new
diagnos
like
occur
analysi
preval
diabet
defin
hypertens
defin
systol
blood
pressur
mmhg
diastol
blood
pressur
mmhg
current
use
blood
pressur
medic
estim
ageand
sexspecif
preval
level
measur
south
african
nation
health
nutrit
examin
survey
sanhan
ageand
sexspecif
rate
diagnosi
diabet
hypertens
estim
survey
ask
individu
histori
high
blood
sugardiabet
histori
high
blood
pressur
tabl
summar
result
survey
proport
newlydiagnos
individu
link
care
start
treatment
soon
diagnosi
set
case
diabet
case
hypertens
base
result
multidiseas
screen
programm
south
africa
sensit
analys
consid
optimist
assumpt
rate
linkag
treatment
servic
sensit
analysi
conduct
assess
potenti
effect
increas
assum
rate
linkag
treatment
servic
follow
diagnosi
three
diseas
although
studi
subsaharan
africa
gener
found
low
rate
linkag
care
follow
diagnosi
mobil
screen
programm
one
south
african
studi
found
artelig
individu
diagnos
homebas
screen
programm
start
art
within
month
diagnosi
newlydiagnos
individu
follow
regularli
provid
counsel
hiv
care
high
rate
treatment
uptak
therefor
possibl
good
followup
counsel
tabl
summar
result
sensit
analysi
figur
show
expect
yield
multidiseas
screen
programm
sensit
analysi
higher
assum
rate
linkag
associ
substanti
increas
number
newlytr
individu
rel
predict
main
analysi
exampl
twice
mani
newlytr
hivposit
adult
result
multidiseas
screen
programm
predict
main
analysi
howev
number
infect
avert
less
doubl
sensit
analysi
high
level
hiv
diagnosi
alreadi
achiev
south
africa
thu
margin
gain
increas
hiv
test
linkag
care
newlydiagnos
individu
modest
model
conserv
assum
individu
previous
diagnos
hivposit
initi
art
higher
rate
test
posit
limit
model
consid
possibl
individu
previous
diagnos
whether
hiv
diabet
hypertens
initi
treatment
diagnosi
may
like
initi
treatment
test
posit
figur
yield
multidiseas
screen
enhanc
linkag
sensit
analysi
conduct
assess
effect
annual
screen
coverag
place
coverag
assum
previous
scenario
number
diabet
hypertens
case
treat
approxim
half
number
main
analysi
tabl
howev
number
newli
treat
hiv
case
number
hiv
infect
avert
half
main
analysi
reflect
satur
effect
may
expect
level
hiv
diagnosi
alreadi
high
ie
margin
return
increas
frequenc
test
diminish
background
rate
hiv
diagnosi
increas
figur
show
expect
yield
multidiseas
screen
scenario
result
similar
main
text
figur
yield
multidiseas
screen
reduc
annual
screen
coverag
addit
complic
consid
screen
assay
may
poor
sensit
andor
specif
case
hiv
convent
diagnos
use
two
rapid
test
specif
gener
close
fals
posit
consequ
uncommon
howev
case
hypertens
diabet
test
commonli
use
communitybas
test
campaign
typic
poor
specif
sensit
use
accur
test
feasibl
context
mobil
test
campaign
case
diabet
gold
standard
diagnosi
requir
fast
prior
receiv
sugar
dose
follow
hour
later
blood
measur
case
hypertens
gold
standard
diagnosi
requir
sever
measur
differ
time
ideal
outsid
clinic
set
diagnost
criteria
assum
case
diabet
singl
systol
blood
pressur
measur
mmhg
diastol
blood
pressur
measur
mmhg
case
hypertens
may
poor
sensit
campaign
model
like
miss
mani
case
undiagnos
diseas
addit
poor
specif
screen
method
may
lead
substanti
overdiagnosi
ie
yield
multidiseas
screen
preval
diseas
newli
diagnos
figur
main
text
may
exagger
howev
import
note
south
african
studi
base
assumpt
treatment
initi
diagnosi
consid
individu
treat
receiv
repeat
test
health
facil
confirm
initi
diagnosi
thu
fraction
newli
treat
figur
main
text
unlik
overst
unless
remain
substanti
overdiagnosi
even
confirmatori
test
studi
posit
predict
valu
initi
diagnosi
conserv
estim
fraction
receiv
repeat
test
subsequ
start
treatment
case
diabet
case
hypertens
estim
conserv
mani
fail
initi
treatment
reason
neg
repeat
test
impli
true
fraction
newli
diagnos
could
low
case
diabet
case
hypertens
addit
exist
epidemiolog
data
nationallevel
hiv
preval
among
male
femal
popul
countri
use
calibr
target
baselin
model
use
avail
report
hiv
preval
among
key
riskgroup
includ
men
sex
men
msm
peopl
inject
drug
pwid
femal
sex
worker
better
character
heterogen
natur
hiv
epidem
countri
tabl
provid
list
data
point
use
calibr
subgroup
specif
hiv
preval
countri
weak
infrastructur
reproduct
health
servic
women
nigeria
evid
high
rate
women
third
attend
antenat
care
servic
pregnanc
low
rate
contracept
use
famili
plan
servic
well
low
coverag
pmtct
servic
hiv
pregnant
women
famili
plan
key
factor
achiev
sustain
develop
goal
contracept
center
proper
famili
plan
nigeria
made
progress
improv
use
contracept
last
decad
coverag
remain
incred
low
appli
spectrum
packag
construct
baselin
represent
hiv
epidem
nigeria
calibr
model
avail
epidemiolog
data
preval
hiv
nation
level
among
key
risk
group
list
tabl
appli
famplan
modul
creat
three
scenario
describ
integr
hiv
reproduct
health
servic
nigeria
includ
baselin
model
reproduct
health
among
nigerian
women
absenc
intervent
two
addit
intervent
expans
pmtct
coverag
among
hiv
pregnant
women
famili
plan
servic
contracept
use
among
women
baselin
scenario
pmtct
coverag
hiv
pregnant
women
contracept
use
preval
maintain
fix
level
given
nation
plan
elimin
option
b
develop
baselin
scenario
reduc
coverag
option
b
linear
reduct
maintain
overal
level
coverag
next
decad
figur
appli
spectrum
packag
construct
nation
model
hiv
epidem
kenya
use
epidemiolog
target
describ
tabl
use
model
estim
hivrel
impact
intervent
screen
treatment
hiv
ncd
kenya
statu
quo
statu
quo
model
character
maintain
coverag
art
ear
fix
level
next
decad
hivrel
scenario
follow
framework
project
search
model
joint
communityoutreach
campaign
hiv
ncd
screen
next
decad
simplic
assum
program
could
reach
popul
annual
basi
success
screen
elig
adult
hiv
diabet
hypertens
model
potenti
impact
hivrel
outcom
assum
uptak
art
among
newli
diagnos
hiv
individu
ie
assum
target
level
linkag
engag
hiv
care
diagnosi
correspond
reduct
unmet
need
art
among
hiv
popul
next
decad
model
linear
increas
rate
art
coverag
among
subgroup
sensit
analysi
project
impact
program
moder
art
uptak
accord
south
africa
analysi
see
main
report
ncd
scenario
due
limit
spectrum
packag
concurr
simul
hiv
ncd
adopt
simplifi
approach
model
impact
integr
ncd
program
term
number
new
diagnosi
treatment
use
repres
nation
survey
estim
proport
adult
awar
receiv
medic
hypertens
diabet
base
number
adult
screen
expect
uptak
treatment
estim
impact
integr
intervent
awar
treatment
hypertens
diabet
figur
intervent
commun
constitut
repres
adult
popul
year
age
assum
screen
uptak
treatment
uptak
follow
diagnosi
hiv
hypertens
diabet
sensit
analys
evalu
model
outcom
affect
particular
paramet
includ
lower
art
uptak
follow
diagnosi
hiv
reduc
intervent
reach
lower
sensit
specif
screen
test
hypertens
diabet
appropri
also
report
impact
intervent
cost
costeffect
estim
base
sensit
analys
present
figur
sensit
analys
lower
art
uptak
follow
diagnosi
art
uptak
describ
main
commiss
report
among
newli
diagnos
number
new
hiv
infect
project
fall
correspond
new
infect
avert
compar
statu
quo
scenario
sensit
analys
around
antiretrovir
treatment
uptak
suggest
even
treatment
initi
among
newli
diagnos
integr
scenario
would
result
reduct
hiv
incid
rel
statu
quo
scenario
correspond
infect
avert
wherea
uptak
among
newli
diagnos
would
result
estim
million
discount
dali
avert
rel
statu
quo
uptak
would
result
estim
million
discount
dali
avert
rel
statu
quo
decreas
art
uptak
scenario
hiv
compon
intervent
would
remain
highli
cost
effect
rel
gdp
per
capita
estim
cost
per
dali
avert
versu
statu
quo
scenario
consid
less
ambiti
intervent
scenario
commun
consist
vs
popul
year
age
target
year
scenario
estim
million
individu
year
age
older
would
screen
total
cost
commun
mobil
hiv
test
would
million
cost
ncd
test
million
compar
increment
cost
per
hivrel
dali
avert
base
case
cost
per
dali
avert
reduc
intervent
scenario
would
somewhat
higher
still
order
magnitud
lower
per
capita
gdp
due
mathemat
structur
spectrum
model
aggreg
definit
simul
paramet
pertain
art
uptak
program
coverag
translat
final
number
peopl
receiv
art
model
sensit
analysi
variat
program
coverag
art
uptak
similar
level
result
similar
result
term
chang
number
new
infect
aid
death
avert
model
ncd
kenya
assum
criteria
use
search
studi
hypertens
defin
systol
diastol
mm
hg
three
consecut
measur
selfreport
current
use
antihypertens
prediabet
defin
random
blood
glucos
mmoll
mgdl
diabet
defin
random
blood
glucos
mmoll
mgdl
sensit
analys
examin
diagnost
sensit
specif
test
compar
hypertens
base
ambulatori
blood
pressur
mm
hg
ie
repeat
measur
cours
day
clinic
measur
threshold
mm
hg
mean
sensit
mean
specif
metaanalys
diagnosi
diabet
dysglycemia
threshold
mmoll
random
blood
glucos
slightli
higher
assum
sensit
specif
compar
oral
glucos
toler
test
estim
indic
particip
hypertens
would
identifi
particip
diabet
dysglycemia
would
identifi
sensit
analys
account
miss
diagnos
adjust
ncd
care
cascad
estim
figur
intervent
commun
follow
screen
estim
individu
hypertens
treatment
would
identifi
percent
hypertens
individu
diagnosi
increas
receiv
medic
versu
without
falseneg
intervent
commun
individu
diabet
would
newli
diagnos
percent
individu
diabet
dysglycemia
increas
receiv
medic
versu
without
falseneg
expect
individu
falseneg
screen
result
may
identifi
hypertens
diabet
initi
clinic
care
subsequ
round
communitybas
test
health
care
encount
regard
communitybas
screen
cost
reduct
number
individu
hypertens
diabet
would
correspond
increas
cost
per
true
posit
diagnos
estim
margin
cost
per
case
identifi
would
blood
glucos
screen
provid
conjunct
hiv
commun
health
campaign
cost
jointli
share
hypertens
screen
specif
clinic
blood
pressur
screen
preval
hypertens
approxim
posit
screen
falseposit
given
specif
random
blood
glucos
preval
diabet
number
falseposit
substanti
may
account
posit
test
result
although
substanti
falseposit
test
result
hypertens
diabet
mani
individu
may
increas
risk
chronic
condit
may
benefit
clinic
encount
educ
lifestyl
impact
posit
screen
result
condit
fuller
workup
may
warrant
repeat
screen
differ
test
may
appropri
includ
ambulatori
blood
pressur
screen
oral
glucos
toler
expect
mani
individu
falseposit
test
result
ie
misdiagnos
hypertens
diabet
would
identifi
initi
clinic
care
albeit
health
care
cost
proport
incorrect
test
result
may
reduc
twostag
screen
use
screen
test
higher
sensit
specif
becom
afford
wide
avail
individu
screen
posit
base
random
blood
glucos
receiv
screen
per
test
estim
cost
per
case
identifi
would
increas
approxim
kenya
right
panel
hiv
ncd
scenario
assum
uptak
art
follow
diagnosi
sensit
hypertens
screen
sensit
diabet
screen
appli
spectrum
packag
construct
baselin
represent
hiv
epidem
india
nationallevel
calibr
model
avail
epidemiolog
data
preval
hiv
nation
level
among
key
risk
group
list
tabl
use
model
creat
altern
scenario
integr
hiv
sti
servic
among
msm
fsw
india
due
limit
softwar
design
model
concurr
hiv
sti
program
appli
spectrum
model
studi
impact
integr
hiv
relat
outcom
use
simplifi
approach
estim
potenti
outcom
level
syphili
infect
repres
sti
baselin
assum
prep
coverag
baselin
art
coverag
maintain
estim
level
see
tabl
next
decad
model
potenti
impact
hivrel
outcom
assum
integr
intervent
success
deliv
art
individu
diagnos
hiv
current
art
ie
linkag
engag
correspond
reduct
unmet
need
art
among
hivposit
msm
fsw
accordingli
figur
model
effect
linear
increas
rate
art
coverag
use
extend
version
spectrum
aim
modul
sensit
analysi
reduc
expect
level
art
uptak
line
assumpt
south
african
model
studi
impact
chang
project
epidemiolog
outcom
furthermor
order
estim
potenti
impact
prep
model
two
addit
scenario
implement
oral
prep
among
msm
fsw
low
high
level
coverag
scenario
prep
coverag
increas
linearli
continu
fix
level
prep
adher
assum
prep
stismodel
scenario
due
lack
repres
data
incidencepreval
sti
among
msm
fsw
india
limit
analysi
studi
impact
integr
program
screen
treatment
syphili
infect
moreov
due
complex
model
coepidem
syphili
hiv
infect
india
chose
simplifi
approach
estim
impact
intervent
program
particip
estim
impact
secondari
infect
avert
use
array
avail
estim
literatur
see
tabl
estim
nation
preval
syphili
among
fsw
among
msm
assum
level
preval
among
test
first
year
program
integr
scenario
perform
sensit
analysi
around
uptak
art
among
msm
fsw
baselin
valu
linkag
engag
art
care
conserv
estim
along
select
level
kenya
south
africa
model
figur
compar
trend
number
new
hiv
infect
among
msm
fsw
scenario
reduct
art
uptak
result
similar
reduct
impact
intervent
reduc
total
number
hiv
infect
avert
high
uptak
scenario
low
uptak
scenario
among
msm
among
fsw
nation
level
lower
uptak
reduc
impact
hiv
incid
reduct
compar
baselin
despit
smaller
impact
intervent
save
aid
death
among
msm
fsw
respect
analysi
highlight
sensit
epidemiolog
impact
intervent
level
uptak
essenti
program
coverag
number
peopl
art
given
scenario
base
case
scenario
art
uptak
among
newli
diagnos
msm
fsw
would
avert
dali
art
uptak
dali
would
avert
cost
per
dali
avert
would
increas
uptak
uptak
lower
uptak
hiv
impact
would
still
highli
cost
effect
rel
per
capita
gdp
costeffect
analys
model
scenario
base
resourc
requir
deliv
intervent
impact
intervent
healthcar
util
impact
intervent
death
disabl
express
disabilityadjust
life
year
dali
resourc
requir
healthcar
util
valu
usd
estim
total
cost
healthcar
perspect
scenario
cost
dali
estim
increment
valu
rel
baselin
addit
intervent
valu
calcul
increment
costeffect
ratio
increment
cost
per
increment
dali
avert
set
intervent
scenario
often
consid
highli
cost
effect
given
countri
net
cost
per
dali
avert
less
percapita
gross
domest
product
gdp
conjunct
commonlyus
standard
essenti
cogniz
afford
feasibl
equiti
evalu
scenario
thu
present
costeffect
result
illustr
rather
prescript
purpos
resourc
requir
consid
first
resourc
requir
hivrel
compon
communitybas
hiv
test
linkag
treatment
kenya
outreach
hiv
test
linkag
treatment
fsw
msm
india
pmtct
nigeria
estim
addit
resourc
requir
integr
servic
hypertens
diabet
screen
linkag
treatment
kenya
syphili
test
linkag
treatment
india
famili
plan
coverag
nigeria
cost
resourc
deriv
literatur
spectrum
model
impactnow
famili
plan
modul
health
care
util
spectrum
model
estim
number
peopl
art
year
personyear
cost
art
countri
appli
estim
hypertens
diabet
kenya
number
peopl
newli
receiv
treatment
base
countryspecif
treatment
rate
hiv
sti
treatment
cost
effect
consid
tenyear
time
horizon
report
valu
year
occur
contrast
hypertens
consid
lifetim
time
horizon
cost
dali
much
medic
resourc
consumpt
dali
avert
occur
lifetim
cost
dali
discount
annual
diabet
could
identifi
percas
estim
lifetim
treatment
cost
instead
present
cost
per
dali
avert
base
populationlevel
model
limit
econom
evalu
narrow
scope
direct
resourc
requir
plu
healthcar
util
reflect
limit
evid
base
integr
hiv
intervent
desir
transpar
simplifi
analysi
adopt
healthcar
perspect
analys
incorpor
cost
client
impact
product
addit
cost
health
system
strengthen
util
servic
societ
outcom
estim
costeffect
may
therefor
conserv
bias
extent
addit
gain
societi
outweigh
addit
cost
health
system
strengthen
necessari
deliveri
intervent
respond
health
care
demand
creat
monetari
valu
present
usd
unless
otherwis
note
cost
deriv
studi
report
monetari
valu
typic
usd
convert
local
currenc
year
use
yearspecif
world
bank
offici
exchang
rate
local
currenc
valu
updat
valu
use
countryspecif
world
bank
deflat
rate
valu
local
currenc
convert
usd
use
yearspecif
world
bank
exchang
rate
follow
procedur
nigeria
chang
et
al
provid
cost
analysi
hybrid
mobil
multidiseas
test
conduct
western
kenya
uganda
part
search
studi
report
hiv
relat
cost
usd
per
person
rang
major
cost
relat
commun
health
campaign
report
joint
cost
hypertens
diabet
screen
rang
report
valu
reflect
margin
cost
screen
given
expenditur
hivrel
cost
author
also
estim
cost
malaria
screen
although
includ
intervent
compon
model
author
also
provid
breakdown
resourc
requir
cost
appendix
cost
hiv
care
kenya
base
report
sharma
ngalesoni
et
al
estim
million
individu
year
age
older
screen
cost
commun
mobil
hiv
test
would
million
cost
ncd
test
million
number
peopl
art
would
increas
addit
cost
million
number
would
increas
addit
peopl
art
million
addit
treatment
cost
hivrel
compon
commun
health
campaign
would
avert
million
dali
discount
cost
million
equival
per
dali
avert
highli
costeffect
estim
individu
moder
high
blood
pressur
current
treatment
would
identifi
assum
uptak
hypertens
treatment
discount
increment
lifetim
healthcar
cost
moderaterisk
highrisk
hypertens
treatment
hypertens
screen
treatment
would
avert
dali
cost
correspond
per
dali
avert
model
scenario
popul
would
increas
would
cost
benefit
reach
dali
avert
assum
preval
diabet
among
adult
kenyan
estim
blood
glucos
screen
conjunct
hiv
commun
health
campaign
would
newli
identifi
individu
diabet
margin
cost
per
case
identifi
standard
glycem
control
individu
diabet
cost
per
dali
avert
approxim
hivrel
compon
hypertens
diabet
compon
intervent
estim
highli
costeffect
cost
screen
pregnant
women
cost
pmtct
hivposit
pregnant
women
deriv
pepfar
report
pilot
expenditur
analysi
pepfar
program
six
countri
cost
estim
averag
expenditur
across
facil
type
report
provid
discuss
variat
cost
across
type
facil
famili
plan
cost
base
health
polici
project
impactnow
model
microsoft
excel
workbook
calcul
varieti
outcom
includ
famili
plan
cost
subsequ
medic
care
util
dali
specif
countri
usersuppli
scenario
abil
chang
varieti
paramet
write
program
project
outcom
analys
famili
plan
intervent
model
cost
dali
per
personyear
contracept
use
use
project
outcom
end
model
period
base
hypothes
proport
women
contracept
coverag
without
intervent
project
number
women
reproduct
age
reli
impactnow
default
valu
mix
contracept
use
nigeria
ie
proport
women
use
variou
method
peryear
cost
method
later
deriv
guttmach
institut
ad
report
perperson
annual
art
cost
pepfar
annual
treatment
report
person
art
hivrel
dali
year
scenario
obtain
spectrum
describ
health
polici
project
impactnow
model
use
estim
cost
consequ
famili
plan
health
medic
outcom
reli
default
valu
nigeria
impactnow
model
increas
increas
access
famili
plan
highli
costeffect
approach
costsav
threshold
net
cost
approxim
per
dali
avert
consid
two
approach
provid
hiv
sti
servic
fsw
msm
india
avahan
initi
success
reduc
hiv
risk
among
popul
done
comprehens
intervent
among
fsw
increment
cost
per
infect
avert
estim
increment
cost
per
dali
avert
estim
avahan
initi
multifacet
includ
hiv
test
peer
educ
sti
treatment
manag
condom
promot
varieti
activ
commun
mobil
advocaci
chang
enabl
environ
overal
cost
per
client
per
year
second
approach
consid
reach
msm
fsw
respondentdriven
sampl
rd
wherebi
msm
fsw
incentiv
visit
program
site
refer
other
servic
site
would
receiv
hiv
sti
test
treatment
estim
cost
per
person
test
hiv
approach
approxim
although
rd
approach
evalu
larg
scale
prefer
model
scenario
may
afford
achiev
high
level
coverag
multifacet
mechan
hiv
sti
risk
reduct
avahan
would
necessit
far
complex
simul
model
identifi
syphilisrel
dali
estim
specif
india
dali
per
preval
syphili
case
calcul
use
method
korenromp
et
al
brief
global
dali
syphili
estim
global
burden
diseas
studi
intervent
scenario
recruit
hiv
test
referr
cost
would
increas
art
uptak
among
diagnos
art
coverag
would
increas
base
case
overal
program
test
treatment
without
prep
would
highli
costeffect
avert
dali
per
dali
avert
increment
cost
base
case
cost
neither
prep
scenario
coverag
would
cost
effect
increment
cost
per
dali
avert
vs
prep
scenario
prep
may
appear
costeffect
among
msm
fsw
nation
level
may
prove
costeffect
region
countri
incid
particularli
high
popul
addit
syphili
screen
treatment
hiv
test
treatment
prep
scenario
would
like
highli
costeffect
program
would
test
individu
diagnos
treat
case
increment
cost
estim
dali
per
preval
case
estim
avert
dali
first
year
per
dali
avert
total
cost
test
year
would
increas
scaleup
coverag
coverag
among
msm
coverag
among
fsw
total
syphili
test
cost
would
maximum
estim
treatment
cost
assum
pessimist
decreas
syphili
preval
result
previou
year
test
sensit
analys
examin
cost
recruit
hiv
test
perperson
cost
similar
avahan
scenario
cost
hiv
test
treatment
prep
would
overal
cost
per
dali
avert
would
reiter
sensit
analysi
reflect
substanti
cost
intervent
reflect
comprehens
natur
avahan
intervent
constru
econom
evalu
avahan
initi
author
javier
cepeda
peter
vickerman
natasha
k
martin
aim
model
exercis
assess
impact
scale
harm
reduct
antiretrovir
therapi
art
hiv
transmiss
fatal
overdos
among
pwid
two
differ
epidem
set
russia
offici
data
russian
govern
indic
sever
region
within
ural
siberian
perform
site
year
full
detail
analysi
method
find
found
companion
paper
briefli
analys
highlight
import
heterogen
among
pwid
popul
term
histori
incarcer
ekaterinburg
omsk
sex
ekaterinburg
consequ
stratifi
model
factor
calibr
hiv
preval
data
among
group
see
tabl
develop
dynam
determinist
compartment
model
hiv
transmiss
among
pwid
model
schemat
figur
incorpor
inject
sexual
transmiss
among
pwid
pwid
enter
due
inject
initi
exit
due
cessat
inject
death
overdos
hivrel
death
nonhiv
background
mortal
individu
cycl
harm
reduct
intervent
figur
defin
differ
scenario
recruit
rate
dropout
rate
harm
reduct
scenario
explor
scaleup
high
coverag
needlesyring
program
nsp
defin
receiv
one
steril
syring
per
inject
oat
combin
nsp
oat
program
word
pwid
recruit
onto
program
provid
high
coverag
nsp
oat
harm
reduct
scenario
harm
reduct
intervent
assum
reduc
individu
risk
inject
hiv
transmiss
compar
harm
reduct
rr
k
therefor
rr
rr
k
vari
depend
intervent
examin
nsp
oat
nspoat
henc
assum
nsp
oat
nspoat
reduc
individu
risk
inject
hiv
transmiss
compar
nsp
cofactor
rr
nsp
rr
oat
rr
respect
also
assum
oat
alon
combin
nsp
reduc
risk
art
drop
compar
oat
cofactor
k
definit
k
vari
intervent
nsp
oat
mean
risk
fatal
overdos
cofactor
definit
vari
intervent
mean
art
recruit
model
rate
k
c
int
c
incorpor
impact
oat
intervent
increas
recruit
art
factor
fold
oat
individu
drop
art
rate
k
c
int
c
assum
intervent
incorpor
oat
reduc
art
drop
factor
oat
assum
nsp
impact
art
drop
art
recruit
addit
incorpor
heighten
risk
overdos
first
week
enter
leav
oat
base
data
systematicreview
metaanalysi
henc
incorpor
death
small
proport
enter
oat
proport
enter
enter
x
od
prev
x
rr
odonoat
x
background
overdos
mortal
rate
od
prev
protect
overdos
prevent
benefit
oat
rr
od
risk
overdos
within
first
four
week
initi
methadon
multipli
durat
risk
week
week
per
year
similarli
come
intervent
incorpor
death
small
proport
exit
oat
exit
exit
x
rr
odoffoat
x
inflow
suscept
pwid
replac
number
pwid
n
ceas
inject
die
due
background
nonhiv
nonoverdos
mortal
lowrisk
pwid
harm
reduct
superscript
lowrisk
never
incarcer
highrisk
ever
incarcer
superscript
male
femal
lowrisk
pwid
harm
reduct
highrisk
pwid
harm
reduct
highrisk
pwid
harm
reduct
inflow
pwid
popul
defin
inject
forc
infect
defin
equat
rr
k
rr
nsp
syring
exchang
rr
k
rr
oat
oat
rr
k
rr
oatnsp
rr
femal
increas
risk
transmiss
among
femal
compar
male
male
sexual
forc
infect
defin
model
calibr
two
citi
differ
epidem
profil
russia
omsk
moder
expand
hiv
epidem
ekaterinburg
high
stabl
hiv
epidem
estim
uncertainti
bound
paramet
use
model
found
tabl
tabl
paramet
use
model
sampl
uncertainti
bound
found
tabl
calibr
hiv
incid
preval
data
account
high
uncertainti
estim
sampl
uniformli
year
inject
durat
overdos
rate
estim
overdos
mortal
rate
approxim
base
publish
estim
pwid
st
petersburg
estim
omsk
ekaterinburg
sampl
includ
global
estim
crude
mortal
rate
pwid
like
higher
rate
russia
attribut
lack
opioid
agonist
oat
restrict
pwid
access
naloxon
pharmaci
poorli
equip
ambul
train
staff
administ
overdoserel
mortal
opioid
agonist
oat
highlight
recent
systemat
review
metaanalysi
individu
methadon
increas
risk
mortal
due
overdos
howev
overdoserel
mortal
rate
within
first
four
week
initi
methadon
per
personyear
per
personyear
first
four
week
discontinu
methadon
comparison
overdoserel
mortal
rate
methadon
per
personyear
sinc
pool
rate
ratio
provid
increas
risk
opioid
overdos
mortal
first
four
week
enter
methadon
first
four
week
exit
methadon
sampl
allcaus
mortal
pool
rate
ratio
period
rr
odonoat
ci
rr
odoffoat
ci
art
coverag
selfreport
data
studi
ekaterinburg
reveal
hivposit
pwid
current
art
assum
art
scaleup
pwid
began
studi
directli
evalu
efficaci
art
prevent
inject
relat
transmiss
howev
find
previou
model
studi
estim
art
efficaci
reduct
transmiss
high
uncertainti
similarli
reduct
hiv
transmiss
observ
bangkok
tenofvir
preexposur
prophylaxi
trial
conduct
among
pwid
thu
estim
rel
reduct
inject
relat
transmiss
approxim
center
around
estim
model
analysi
consist
art
adher
estim
among
pwid
addit
model
follow
intervent
coverag
scenario
base
case
harm
reduct
art
recruit
current
rate
produc
art
coverag
among
hiv
pwid
counterfactu
assum
baselin
coverag
harm
reduct
oat
illeg
hand
nsp
countrywid
minim
provis
art
coverag
calibr
base
selfreport
data
current
art
use
among
hiv
pwid
ekaterinburg
oatnsp
plu
integr
art
recruit
higher
base
case
within
harm
reduct
scaleup
coverag
combin
oat
high
coverag
nsp
pwid
within
year
scaledup
art
hivinfect
pwid
within
harm
reduct
rate
higher
base
case
art
recruit
rate
scenario
assum
pwid
initi
art
combin
harm
reduct
remain
art
drop
harm
reduct
oatnsp
pwid
commun
experi
elev
art
dropout
rate
compar
pwid
oatnsp
project
hiv
preval
among
pwid
hiv
incid
among
pwid
addit
estim
proport
new
hiv
infect
fatal
overdos
avert
calcul
cumul
differ
base
case
intervent
scenario
model
run
divid
expect
number
event
base
case
scenario
present
result
median
interv
perform
sever
sensit
analys
test
impact
model
assumpt
first
examin
impact
hiv
infect
overdos
avert
scenario
persist
proport
popul
access
harm
reduct
exampl
due
unsuit
oat
stimul
injector
barrier
addit
examin
impact
incorpor
lower
nondrug
relat
mortal
rate
per
year
agespecif
mortal
rate
age
russia
compar
basecas
assum
mortal
rate
basecas
scenario
model
project
median
interv
overal
hiv
preval
incid
among
pwid
basecas
found
figur
model
calibr
well
overal
hiv
preval
well
sex
risk
group
shown
see
companion
paper
detail
full
model
calibr
result
intervent
scenario
intervent
coverag
coverag
harm
reduct
intervent
nsp
oat
nspoat
reach
steadi
state
quickli
remain
near
target
coverag
year
figur
base
case
overal
art
coverag
reach
omsk
ekaterinburg
respect
includ
impact
oat
increas
art
recruit
coverag
reach
approxim
overal
among
pwid
intervent
among
pwid
commun
omsk
ekaterinburg
respect
scenario
art
scaleup
time
base
case
rate
coverag
reach
approxim
overal
among
pwid
intervent
among
pwid
commun
omsk
ekaterinburg
respect
discrep
art
coverag
due
reduc
odd
art
discontinu
oat
henc
scenario
highlight
substanti
benefit
integr
art
within
harm
reduct
servic
could
pwid
harm
reduct
also
harm
reduct
drop
also
highlight
valu
integr
oat
art
increas
art
retent
therefor
coverag
assum
pwid
set
would
equal
like
access
harm
reduct
intervent
howev
probabl
pwid
would
abl
access
harm
reduct
intervent
obtain
benefit
eg
pwid
inject
amphetaminetypestimul
would
benefit
opioid
agonist
oat
thu
sensit
analysi
assum
pwid
would
never
access
harm
reduct
intervent
still
maintain
coverag
result
shown
figur
overal
rel
chang
proport
hiv
case
fatal
overdos
avert
affect
minim
rel
chang
baselin
scenario
approxim
scenario
sensit
analysi
similar
find
observ
respect
overdos
avert
largest
rel
chang
found
oat
scenario
sensit
analysi
versu
baselin
rel
chang
addit
examin
impact
reduc
background
mortal
rate
figur
figur
model
schemat
hiv
progress
art
model
compon
among
pwid
model
addit
stratifi
compon
figur
stage
stratifi
inject
risk
indic
superscript
low
risk
high
risk
sex
superscript
j
male
femal
intervent
statu
indic
subscript
k
omsk
art
scaleup
harm
reduct
intervent
overal
coverag
global
level
imposit
margin
tax
financi
transact
long
studi
possibl
mechan
gener
fund
global
health
develop
propon
tax
also
argu
would
discourag
financi
specul
although
financi
transact
tax
exist
sever
countri
govern
highincom
countri
resist
propos
levi
tax
global
level
financi
transact
tax
could
help
financ
new
mechan
ensur
access
medicin
global
health
good
nation
debt
profil
permit
strateg
borrow
may
support
nation
effort
build
health
system
acceler
progress
toward
univers
health
coverag
global
fund
exampl
work
leverag
blend
financ
scheme
combin
grant
loan
buydown
gener
concession
financ
develop
countri
health
programm
region
develop
bank
play
especi
use
role
expand
financ
health
lowand
middleincom
countri
